Search

Author/Creator Berton-Rigaud, Dominique

1. 268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101). (10th December 2020)

Authors:
Berton-Rigaud, Dominique; Vergote, Ignace; Pautier, Patricia; Kryzhanivska, Anna; Angelergues, Antoine; Kornacki, Deanna; Dudzisz-Sledz, Monika; Tian, Chuan; Bourayou, Nawel; Selle, Frederic
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A164
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101). (9th November 2020)

Authors:
Berton-Rigaud, Dominique; Vergote, Ignace; Pautier, Patricia; Kryzhanivska, Anna; Angelergues, Antoine; Kornacki, Deanna; Dudzisz-Sledz, Monika; Tian, Chuan; Bourayou, Nawel; Selle, Frederic
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A294
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Issue 5 (May 2020)

Authors:
Pfisterer, Jacobus; Shannon, Catherine M; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P; Hein, Alexander; Zeimet, Alain G; Hanker, Lars C; Petit, Thierry; Marmé, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 5(2020)
Page Start:
699
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study. Issue 1 (December 2016)

Authors:
Pulford, David; Harter, Philipp; Floquet, Anne; Barrett, Catherine; Suh, Dong; Friedlander, Michael; Arranz, José; Hasegawa, Kosei; Tada, Hiroomi; Vuylsteke, Peter; Mirza, Mansoor; Donadello, Nicoletta; Scambia, Giovanni; Johnson, Toby; Cox, Charles; Chan, John; Imhof, Martin; Herzog, Thomas; Cal...
Journal:
BMC medical ethics
Issue:
Volume 17:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine and Ovarian Carcinosarcoma. (1st November 2014)

Authors:
Berton-Rigaud, Dominique; Devouassoux-Shisheboran, Mojgan; Ledermann, Jonathan A.; Leitao, Mario M.; Powell, Matthew A.; Poveda, Andres; Beale, Philip; Glasspool, Rosalind M.; Creutzberg, Carien L.; Harter, Philipp; Kim, Jae-Weon; Reed, Nicholas Simon; Ray-Coquard, Isabelle
Journal:
International journal of gynecological cancer
Issue:
Volume 24(2014)Supplement 3
Page Start:
S55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer. Issue 7 (15th August 2019)

Authors:
Lorusso, Domenica; Hilpert, Felix; González Martin, Antonio; Rau, Joern; Ottevanger, Petronella; Greimel, Elfriede; Lück, Hans-Joachim; Selle, Frédéric; Colombo, Nicoletta; Kroep, Judith R; Mirza, Mansoor R; Berger, Regina; Pardo, Beatriz; Grischke, Eva-Maria; Berton-Rigaud, Dominique; Martinez-G...
Journal:
International journal of gynecological cancer
Issue:
Volume 29:Issue 7(2019)
Page Start:
1141
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer. Issue 7 (September 2019)

Authors:
Lorusso, Domenica; Hilpert, Felix; González Martin, Antonio; Rau, Joern; Ottevanger, Petronella; Greimel, Elfriede; Lück, Hans-Joachim; Selle, Frédéric; Colombo, Nicoletta; Kroep, Judith R; Mirza, Mansoor R; Berger, Regina; Pardo, Beatriz; Grischke, Eva-Maria; Berton-Rigaud, Dominique; Martinez-G...
Journal:
International journal of gynecological cancer
Issue:
Volume 29:Issue 7(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial. Issue 5 (1st June 2016)

Authors:
González-Martín, Antonio; Pautier, Patricia; Mahner, Sven; Rau, Joern; Colombo, Nicoletta; Ottevanger, Petronella; del Campo, Josep M.; Selle, Frédéric; du Bois, Andreas; Gadducci, Angiolo; García, Yolanda; Berton-Rigaud, Dominique; Marmé, Frederik; Ortega, Eugenia; Martin, Nicolas; Bastiere-Truc...
Journal:
International journal of gynecological cancer
Issue:
Volume 26:Issue 5(2016)
Page Start:
898
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial. Issue 5 (June 2016)

Authors:
González-Martín, Antonio; Pautier, Patricia; Mahner, Sven; Rau, Joern; Colombo, Nicoletta; Ottevanger, Petronella; del Campo, Josep M.; Selle, Frédéric; du Bois, Andreas; Gadducci, Angiolo; García, Yolanda; Berton-Rigaud, Dominique; Marmé, Frederik; Ortega, Eugenia; Martin, Nicolas; Bastiere-Truc...
Journal:
International journal of gynecological cancer
Issue:
Volume 26:Issue 5(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial. Issue 8 (August 2018)

Authors:
Oza, Amit M; Matulonis, Ursula A; Malander, Susanne; Hudgens, Stacie; Sehouli, Jalid; del Campo, Josep M; Berton-Rigaud, Dominique; Banerjee, Susana; Scambia, Giovanni; Berek, Jonathan S; Lund, Bente; Tinker, Anna V; Hilpert, Felix; Vázquez, Isabel Palacio; D'Hondt, Véronique; Benigno, Benedict; ...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 8(2018)
Page Start:
1117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗